Transfer Pricing Benchmarking
Access timely, comprehensive data on profit margins and royalty rates — automated insights for strategic intercompany transactions
A saved example of what you can collect and monitor with Jsonify. Create your own version in Jsonify.
Build this in JsonifyYour original goal is prefilled.
Goal
i want to get comprehensive, timely data on arm's length profit margins and royalty rates for comparable intercompany transactions from public financial filings and global intellectual property registry websites.
Source coverage
- sec.gov
- marketwatch.com
- edgar-online.com
- royaltyrange.com
- ipo.gov.uk
- uspto.gov
- spglobal.com
- bloomberg.com
- morningstar.com
Sample data
Illustrative sample data from the original configuration, not live or verified results.
| id | Source | Transaction | Industry | Royalty Rate (%) | Profit Margin (%) | Year |
|---|---|---|---|---|---|---|
| 1 | https://sec.gov/edgar/searchedgar/companysearch.html | Syncrude Oil Sands Project - Alberta Crown Agreement | Energy / Oil & Gas | 1.0 | 10.0 | 1975 |
| 2 | https://edgar-online.com/companies | Cystic Fibrosis Drug License (Trikafta) | Biotech / Pharma | 9.0 | 30.0 | 2020 |
| 3 | https://edgar-online.com/companies | Respiratory Inhaler Drug License (Trelegy Ellipta) | Pharmaceuticals | 6.5 | 18.0 | 2022 |
| 4 | https://edgar-online.com/companies | Multiple Sclerosis Drug License (Tysabri) | Biotech / Pharma | 18.0 | 35.0 | 2017 |
| 5 | https://edgar-online.com/companies | Oncology Drug License (Imbruvica) | Biotech / Pharma | 6.0 | 50.0 | 2013 |
| 6 | https://edgar-online.com/companies | Genetic Disorder Therapy License (Evrysdi) | Biotech / Pharma | 10.0 | 20.0 | 2023 |
| 7 | https://edgar-online.com/companies | Prostate Cancer Drug License (Xtandi) | Biotech / Pharma | 4.0 | 15.0 | 2016 |
| 8 | https://edgar-online.com/companies | Hematology Drug License (Promacta) | Biotech / Pharma | 8.0 | 25.0 | 2019 |
| 9 | https://edgar-online.com/companies | Psoriasis Drug License (Tremfya) | Pharmaceuticals | 7.0 | 15.0 | 2021 |
| 10 | https://edgar-online.com/companies | Kidney Cancer Drug License (Cabometyx/Cometriq) | Biotech / Pharma | 3.0 | 30.0 | 2021 |
| 11 | https://bloomberg.com/markets | Smartphone Patent Portfolio Licensing Deal | Technology / Electronics | 5.0 | 30.0 | 2025 |
| 12 | https://marketwatch.com/tools/quotes | Cloud Software Subscription License Agreement | Software / IT Services | 10.0 | 40.0 | 2024 |
| 13 | https://spglobal.com/en/research-insights | Solar Panel Technology License | Energy / Renewables | 4.0 | 18.0 | 2023 |
| 14 | https://morningstar.com/stocks | Retail Brand Licensing Agreement | Retail / Fashion | 8.0 | 12.0 | 2022 |
| 15 | https://ipo.gov.uk/p-ipsum | Aerospace Patent Licensing Framework (UK) | Aerospace | 7.0 | 18.0 | 2024 |
| 16 | https://uspto.gov/patents/search | Green Technology Patent License (US) | Clean Energy | 4.5 | 20.0 | 2025 |
| 17 | https://marketwatch.com/tools/quotes | Augmented Reality Device Patent License | Consumer Electronics | 4.5 | 25.0 | 2024 |
| 18 | https://spglobal.com/en/research-insights | Electric Vehicle Charging Tech License | Automotive | 3.0 | 10.0 | 2023 |
| 19 | https://bloomberg.com/markets | Media Streaming Platform IP License | Media / Entertainment | 5.0 | 25.0 | 2024 |
| 20 | https://morningstar.com/stocks | E-commerce Platform Service License | Retail / E-commerce | 2.0 | 8.0 | 2024 |
| 21 | https://ipo.gov.uk/p-ipsum | Trademark Licensing (Apparel) | Apparel / Fashion | 6.0 | 15.0 | 2023 |
| 22 | https://uspto.gov/patents/search | Food & Beverage Brand License (US) | Food & Beverage | 5.0 | 12.0 | 2025 |
| 23 | https://marketwatch.com/tools/quotes | Biotech Licensing Deal (Experimental Drug) | Pharmaceuticals | 12.0 | 22.0 | 2024 |
| 24 | https://bloomberg.com/markets | Industrial Equipment Patent Transfer | Manufacturing | 3.5 | 15.0 | 2023 |
| 25 | https://morningstar.com/stocks | Telecom Equipment License Agreement | Telecommunications | 2.0 | 10.0 | 2025 |
| 26 | https://spglobal.com/en/research-insights | EV Battery Technology License | Automotive / Energy | 4.0 | 8.0 | 2024 |
| 27 | https://marketwatch.com/tools/quotes | Financial Analytics Software License | FinTech | 6.0 | 20.0 | 2023 |
| 28 | https://bloomberg.com/markets | CVD Semiconductor Manufacturing License | Industrial Manufacturing | 15.0 | 35.0 | 2025 |
| 29 | https://morningstar.com/stocks | Automotive Software Platform License | Automotive / Technology | 6.0 | 15.0 | 2024 |
| 30 | https://royaltyrange.com/ | Benchmark IP Licensing Study (Global) | Mixed Sectors | 8.0 | 20.0 | 2025 |
Insights and analytics
- Average Arm's Length Profit Margin (metric)
- Average Royalty Rate (metric)
- Profit Margin Trends Over Time (line)
- Top 10 Comparable Companies by Profit Margin (bar)
- Royalty Rate Distribution by Industry (donut)
- Detailed Intercompany Transaction Data (table)
- Top 5 Royalty Rates by Country (horizontal_bar)
- Cumulative Profit Margin Analysis (area)
- Key Observations on Profit Margins and Royalties (insights)
- Royalty Rate Trends Over Time (line)
- Source Contribution to Data Pool (pie)
- Recent Filings from SEC and IPO Registries (table)
Change notifications
- New Royalty Rate Found — new data available from royaltyrange.com royaltyrange.com
- Profit Margin Change Detected — profit margin updated for 2025 sec.gov
- New Filing Available — recent filing added for Q4 2025 edgar-online.com
- Data Unavailable — data missing from global registry ipo.gov.uk
- Coverage Gap Detected — missing data for healthcare sector spglobal.com
Integrations and delivery
- api
- google-sheets
- salesforce
Make this your own
Start with this goal in Jsonify, then choose the sources and data you need.
Build this in Jsonify